Cognitive Effects of Reducing First-Generation Antipsychotic Dose Compared to Switching to Ziprasidone in Long-Stay Patients with Schizophrenia

Cognitive Effects of Reducing First-Generation Antipsychotic Dose Compared to Switching to Ziprasidone in Long-Stay Patients with Schizophrenia

<b>Background:</b> Cognitive impairment is a core symptom of schizophrenia and is associated with functional outcomes. Improving cognitive function is an important treatment goal. Studies have reported beneficial cognitive effects of the second-generation antipsychotic (SGA) ziprasidone....

Full description

Bibliographic Details
Main Authors: Jan P. A. M. Bogers, Jasper A. Blömer, Lieuwe de Haan
Format: Article
Language:English
Published: MDPI AG 2024-04-01
Series:Journal of Clinical Medicine
Subjects:
long-stay schizophrenia
cognition
cognitive function
antipsychotics
ziprasidone
dose reduction
Online Access:https://www.mdpi.com/2077-0383/13/7/2112

Internet

https://www.mdpi.com/2077-0383/13/7/2112

Similar Items